We have been talking about how cross linking can help patients suffering from Keratoconus. We may’ve a bigger issue to confront. What about before cross linking, what about the diagnosis and screening of Keratoconus. It is important for patients with Keratoconus to be screened as early as possible. The best results with corneal cross linking eye procedure are obtained when the disorder is arrested early. As the disease progresses the loss of visual acuity increases dramatically, and the earlier it is detected the easier and higher possibility that full visual acuity returns. You may want to read some frequently asked questions on keratoconus and cross linking.
Some symptoms of Keratoconus are blurry vision, increased light sensitivity, eye strain, headaches/general eye pain, eye irritation/excessive eye rubbing. A caution should be noted that these symptoms can also be indications of other eye problems. That is why it i important to see a keratoconus expert. The doc in conjunction with measurement of the curvature of the cornea, a depth map and examining the eyes can identify the disease more early and accurately.
From a doctor’s perspective, as they physically examine the eye with a microscope, the signs they would be looking for are corneal thinning, Fleischer’s ring, Vogt’s striae, and apical scarring. The measuring of the corneal curvature can be done three different ways: first would be keratometry, second is corneal tomography, and third is a corneal OCT. Though all three should performed for increasing the accuracy of the measurement.
Now that you have a basic understanding of importance of early detection try our quiz on keratoconus.
We have been receiving a lot of questions from patients via social media and telephone calls. People out there are confused regarding the safety and efficacy of the various advertised treatment methods for keratoconus. This is a quick recap of the currently available interventions to help people suffering from keratoconus eye disease. We have Intacs, Cornea Cross Linking, DALK and Corneal transplant. DALK and Corneal Transplant are surgical techniques and thus are not in the purview of the FDA. Let us confine our discussion today than to Intacs and Cross Linking for keratoconus eye disease.
Intacs for Keratoconus are FDA approved
Yes Intacs are the only intracorneal ring implants approved by FDA. Others like Ferras rings are not approved and cannot be sold in USA. Dr. Khanna is one of the participants in an Institutional Review Board monitoring by Integrview. This ongoing oversight ensures that the results are safe.
Is Corneal Cross linking FDA approved?
There are three types of Corneal cross linking available in the US today.
- FDA approved : There is one and only one FDA approved – KXL device and riboflavin called Photrexa manufactured by Avedro. This means that Avedro did a clinical study to demonstrate the safety and efficacy of their formulation with their unique device. Data was submitted to the FDA. Federal Drug and Administration studied the reports. They asked questions and requested more data. Once this was reviewed FDA approved the Avedro method.
- Clinical studies : There are clinical studies being performed by different groups like the AECOS and CXL study groups. FDA has not given the green light on them.
- God Given: These are devices which doctors cannot explain how they arrived in their offices or surgery rooms. The data from these unexplained devices is not being submitted to FDA nor even peer review. No one knows what drugs are being used.
Which one should you use?
FDA ensures the safety of our eyes. They review the statistical data to keep us safe. Therefore when comparing different treatments it is easier for us to know which is safer.
Since there is only one FDA approved cross linking procedure, choose AVEDRO Cornea Cross Linking.
Learn more about treatment modalities for keratoconus.
We have been talking about the advantages of epithelium off cross linking. This from of cross linking has shown to work in numerous studies across the world.
But are all delivery methods the same? Certain machines hope the patient keeps looking at the UV light. Have you tried staring at something for 30 minutes. As a kid you may have played the stare off game. Its tough to do it especially in Los Angeles with the dry weather.
The solution in this fight against keratoconus is to involve a pupil tracker. In the above video you will see it in action. If the eye moves away from the light, the UV delivery and timer will stop. You can set how much movement you are willing to allow.
This increases the safety. One can definitely know that 30 minutes was delivered. It can avoid a situation where a fidgety patients moves and receives only 20 minutes of the radiation. Increasing safety also relaxes the patients. Most of the people requiring this intervention against Keratoconus eye disease are teenagers. Pupil tracking rocks.
Epithelium off Cornea collagen cross linking (CXL) is not voodoo. We realize that early in new technology a lot of unfounded claims like epi on CXL being Better than epi off might be made. It behooves us clinicians to present proof to peers.
There is a symbiosis between diagnostic technology and treatments. We will take help of Carl Zeiss Ocular coherence tomography to demonstrate the effectiveness of epi off CXL.
Here is a High Density picture of a keratoconus cornea before any treatment. It is early keratoconus in a young girl. This is the best time to intervene to treat Keratoconus. Look how uniform the picture is. The top layer of epithelium can be clearly seen. We remove this layer with laser or as Professor Theo Seiler recommends with ethyl alcohol.
Epithelium prevents riboflavin from entering the stroma and hinders the UV absorption. Look at the picture below. You can clearly see a haze which ends around 80 % depth as a line of demarcation.
The same line of demarcation after cornea cross linking is better highlighted in they colored OCT of the Cornea.
If you are suffering from Keratoconus Call 805-283-6520 to see if cross linking of cornea is the best option for you.
or Does It really work?
We pose this question as many medical insurances deny patients reimbursement for cornea cross linking to treat keratoconus. Many parents also pose this question as their own optometrists were unaware of the benefits of cross linking the cornea.
We are going to turn to Australia for a peer review objective answer to this question. Our Australian colleagues performed a study which has been vetted by our peers. The Australian keratoconus experts selected 100 eyes with progressive keratoconus eye disease. They divided them into 2 groups. One would receive Conventional cornea cross linking while the other would have no intervention ( like your insurance company would want). They measured various data like vision, cornea thickness, and curvature of the cornea at various intervals over a period of 3 years.
Are you ready for the results? Can you guess what they showed?
Yes Conventional Cross Linking with UV-A applied on riboflavin soaked eyes was able to prevent steepening of the cornea. It preserved vision both uncorrected and best corrected. It also improved the shape and vision in many instances. We are so convinced by the results we would not be able to repeat it here in the United States. For we would not condemn any kid with keratoconus to be in the control group. The benefits are so obvious. Like society eradicated Polio it is time to wipe away keratoconus eye disease.
Feel Free to print the abstract from the respected Journal Ophthalmology which is attached as an image to show your doubting doc, illogical insurance rep or obstinate optometrist.
BMW on the autobahn is a hair rising experience. Now our German friends want to bring that concept to cxl or corneal cross linking. You may have heard of accelerated cornea cross linking? This is cxl with 10 minutes of UV radiation treatment, In the newest version they propose treatment of only 5 minutes utilizing 18 mw/cm2 of UV radiation.
This would of great benefit to patients. The amount of time they have to stare at the blue light would decrease. Exposure of the cornea to the elements would be less.
We would like to quote the results of the study here ” The mean follow-up time was 21.7 ± 7.2 months (range, 12-34 months). No statistically significant changes were found in the mean corrected distance visual acuity, corneal astigmatism, Kmean, Kflat, Ksteep, corneal pachymetry (at the apex and at the thinnest point), and corneal densitometry at follow-up. A significant reduction of Kmax, index of surface variance, index of vertical asymmetry, and Km of the posterior corneal surface (Km(B)) was observed (Kmax: P = 0.018; index of surface variance: P = 0.016; index of vertical asymmetry: P = 0.038; Km(B): P = 0.008). No complications were reported during the postoperative follow-up period in this study.”
Our question for the authors are. 1) How deep was the demarcation line?
2) was any comparison made to conventional cross linking?
Other papers or followup studies should be address the questions.
Dr.Khanna is a Keratoconus Expert. These informative blog posts are for information purposes. They should not replace a careful discussion with you Keratoconus Eye surgeon.
Keratoconus eye disease is no laughing matter. It afflicts teens and can destroy careers. We need to accelerate our fight against this vicious disease. At the same time we have to study scientifically the newer protocols. Accelerated cross linking speeds the treatment by decreasing the time of exposure of UV light. This has recently been studied in pediatric keratoconus.
This landmark study from Hong Kong By Surgeons of Royal college is a landmark one. It shows that accelerated cornea cross linking slows the progress of the bulging eye disease. it is the first one to document that only conventional cornea cross linking with its deep demarcation line can actually flatten the cornea. In essence it means that the 30 min api off intervention can halt the progression as well as reverse some of the effects.
The deeper the demarcation line the more the cornea flattening .
Keratoconus Experts in Los Angles thank the authors to bring new meaningful data for mutual benefit.